Experimental & Molecular Medicine,
Год журнала:
2024,
Номер
56(7), С. 1501 - 1512
Опубликована: Июль 1, 2024
Abstract
Recent
substantial
evidence
implicating
commensal
bacteria
in
human
diseases
has
given
rise
to
a
new
domain
biomedical
research:
microbiome
medicine.
This
emerging
field
aims
understand
and
leverage
the
microbiota
derivative
molecules
for
disease
prevention
treatment.
Despite
complex
hierarchical
organization
of
this
ecosystem,
most
research
over
years
relied
on
16S
amplicon
sequencing,
legacy
bacterial
phylogeny
taxonomy.
Although
advanced
sequencing
technologies
have
enabled
cost-effective
analysis
entire
microbiota,
translating
relatively
short
nucleotide
information
into
functional
taxonomic
posed
challenges
until
recently.
In
last
decade,
genome-resolved
metagenomics,
which
reconstruct
microbial
genomes
directly
from
whole-metagenome
data,
made
significant
strides
continues
unveil
mysteries
various
human-associated
communities.
There
been
rapid
increase
volume
whole
metagenome
data
compilation
novel
metagenome-assembled
protein
sequences
public
depositories.
review
provides
an
overview
capabilities
methods
metagenomics
studying
microbiome,
with
focus
investigating
prokaryotic
gut.
Just
as
decoding
genome
its
variations
marked
beginning
genomic
medicine
era,
unraveling
microbes
their
sequence
is
ushering
us
era
Genome-resolved
stands
pivotal
tool
transition
can
accelerate
our
journey
toward
achieving
these
scientific
medical
milestones.
Nature Biotechnology,
Год журнала:
2023,
Номер
41(11), С. 1633 - 1644
Опубликована: Фев. 23, 2023
Abstract
Metagenomic
assembly
enables
new
organism
discovery
from
microbial
communities,
but
it
can
only
capture
few
abundant
organisms
most
metagenomes.
Here
we
present
MetaPhlAn
4,
which
integrates
information
metagenome
assemblies
and
isolate
genomes
for
more
comprehensive
metagenomic
taxonomic
profiling.
From
a
curated
collection
of
1.01
M
prokaryotic
reference
metagenome-assembled
genomes,
define
unique
marker
genes
26,970
species-level
genome
bins,
4,992
them
taxonomically
unidentified
at
the
species
level.
4
explains
~20%
reads
in
international
human
gut
microbiomes
>40%
less-characterized
environments
such
as
rumen
microbiome
proves
accurate
than
available
alternatives
on
synthetic
evaluations
while
also
reliably
quantifying
with
no
cultured
isolates.
Application
method
to
>24,500
metagenomes
highlights
previously
undetected
be
strong
biomarkers
host
conditions
lifestyles
mouse
shows
that
even
uncharacterized
genetically
profiled
resolution
single
strains.
Nutrients,
Год журнала:
2023,
Номер
15(9), С. 2211 - 2211
Опубликована: Май 6, 2023
Short-chain
fatty
acids
(SCFAs)
play
a
key
role
in
health
and
disease,
as
they
regulate
gut
homeostasis
their
deficiency
is
involved
the
pathogenesis
of
several
disorders,
including
inflammatory
bowel
diseases,
colorectal
cancer,
cardiometabolic
disorders.
SCFAs
are
metabolites
specific
bacterial
taxa
human
microbiota,
production
influenced
by
foods
or
food
supplements,
mainly
prebiotics,
direct
fostering
these
taxa.
This
Review
provides
an
overview
SCFAs’
roles
functions,
SCFA-producing
bacteria,
from
microbiological
characteristics
taxonomy
to
biochemical
process
that
lead
release
SCFAs.
Moreover,
we
will
describe
potential
therapeutic
approaches
boost
levels
treat
different
related
diseases.
Nature,
Год журнала:
2023,
Номер
614(7946), С. 125 - 135
Опубликована: Янв. 18, 2023
Abstract
The
human
microbiome
is
an
integral
component
of
the
body
and
a
co-determinant
several
health
conditions
1,2
.
However,
extent
to
which
interpersonal
relations
shape
individual
genetic
makeup
its
transmission
within
across
populations
remains
largely
unknown
3,4
Here,
capitalizing
on
more
than
9,700
metagenomes
computational
strain-level
profiling,
we
detected
extensive
bacterial
strain
sharing
individuals
(more
10
million
instances)
with
distinct
mother-to-infant,
intra-household
intra-population
patterns.
Mother-to-infant
gut
was
considerable
stable
during
infancy
(around
50%
same
strains
among
shared
species
(strain-sharing
rate))
remained
detectable
at
older
ages.
By
contrast,
oral
occurred
horizontally
enhanced
by
duration
cohabitation.
There
substantial
cohabiting
individuals,
12%
32%
median
strain-sharing
rates
for
microbiomes,
time
since
cohabitation
affected
age
or
genetics
did.
Bacterial
additionally
recapitulated
host
population
structures
better
species-level
profiles
Finally,
taxa
appeared
as
efficient
spreaders
modes
were
associated
different
predicted
phenotypes
linked
out-of-host
survival
capabilities.
microorganism
that
describe
underscores
relevance
in
studies
5
,
especially
those
non-infectious,
microbiome-associated
diseases.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Фев. 16, 2024
Abstract
The
human
gastrointestinal
tract
is
populated
with
a
diverse
microbial
community.
vast
genetic
and
metabolic
potential
of
the
gut
microbiome
underpins
its
ubiquity
in
nearly
every
aspect
biology,
including
health
maintenance,
development,
aging,
disease.
advent
new
sequencing
technologies
culture-independent
methods
has
allowed
researchers
to
move
beyond
correlative
studies
toward
mechanistic
explorations
shed
light
on
microbiome–host
interactions.
Evidence
unveiled
bidirectional
communication
between
central
nervous
system,
referred
as
“microbiota–gut–brain
axis”.
microbiota–gut–brain
axis
represents
an
important
regulator
glial
functions,
making
it
actionable
target
ameliorate
development
progression
neurodegenerative
diseases.
In
this
review,
we
discuss
mechanisms
As
provides
essential
cues
microglia,
astrocytes,
oligodendrocytes,
examine
communications
microbiota
these
cells
during
healthy
states
Subsequently,
diseases
using
metabolite-centric
approach,
while
also
examining
role
microbiota-related
neurotransmitters
hormones.
Next,
targeting
intestinal
barrier,
blood–brain
meninges,
peripheral
immune
system
counteract
dysfunction
neurodegeneration.
Finally,
conclude
by
assessing
pre-clinical
clinical
evidence
probiotics,
prebiotics,
fecal
transplantation
A
thorough
comprehension
will
foster
effective
therapeutic
interventions
for
management
Journal of Infection,
Год журнала:
2023,
Номер
87(4), С. 287 - 294
Опубликована: Июль 17, 2023
BackgroundArtificial
intelligence
(AI),
machine
learning
and
deep
(including
generative
AI)
are
increasingly
being
investigated
in
the
context
of
research
management
human
infection.ObjectivesWe
summarise
recent
potential
future
applications
AI
its
relevance
to
clinical
infection
practice.Methods1,617
PubMed
results
were
screened,
with
priority
given
trials,
systematic
reviews
meta-analyses.
This
narrative
review
focusses
on
studies
using
prospectively
collected
real-world
data
validation,
translational
potential,
such
as
novel
drug
discovery
microbiome-based
interventions.ResultsThere
is
some
evidence
utility
applied
laboratory
diagnostics
(e.g.
digital
culture
plate
reading,
malaria
diagnosis,
antimicrobial
resistance
profiling),
imaging
analysis
pulmonary
tuberculosis
diagnosis),
decision
support
tools
sepsis
prediction,
prescribing)
public
health
outbreak
COVID-19).
Most
date
lack
any
validation
or
metrics.
Significant
heterogeneity
study
design
reporting
limits
comparability.
Many
practical
ethical
issues
exist,
including
algorithm
transparency
risk
bias.ConclusionsInterest
development
AI-based
for
undoubtedly
gaining
pace,
although
appears
much
more
modest.
Best Practice & Research Clinical Gastroenterology,
Год журнала:
2023,
Номер
62-63, С. 101828 - 101828
Опубликована: Фев. 1, 2023
Gut
microbiota
plays
a
fundamental
role
within
human
health,
and
exerts
key
functions
the
body.
Diet
is
one
of
most
powerful
modulators
gut
composition.
This
complex
interplay
involves
also
immune
system
intestinal
barrier,
highlighting
central
diet
in
pathogenesis
treatment
multiple
diseases.
In
this
review
article
we
will
paint
landscape
effects
specific
dietary
nutrients,
detrimental
or
beneficial
outcomes
different
patterns,
on
composition
microbiota.
Moreover,
discuss
potential
application
as
therapeutic
modulator
microbiota,
including
cutting-edge
ways
exploitation,
use
components
adjuvants
to
promote
microbial
engraftment
after
fecal
transplantation,
personalized
nutritional
approaches,
targeted
patient
microbiome.